JP Morgan Chase
IHE icon

JP Morgan Chase’s iShares US Pharmaceuticals ETF IHE Stock Holding History

JP Morgan Chase’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5M Buy
553,812
+178,066
+47% +$16M ﹤0.01% 1398
2026
Q1 		$31.6M Buy
375,746
+162,941
+77% +$14.3M ﹤0.01% 1696
2025
Q4 		$18.1M Buy
212,805
+100,426
+89% +$8.02M ﹤0.01% 2153
2025
Q3 		$8.15M Buy
112,379
+1,443
+1% +$99.6K ﹤0.01% 2905
2025
Q2 		$7.27M Buy
110,936
+98,352
+782% +$6.4M ﹤0.01% 2823
2025
Q1 		$888K Sell
12,584
-175,983
-93% -$12.2M ﹤0.01% 4434
2024
Q4 		$12.4M Buy
188,567
+180,285
+2,177% +$12.4M ﹤0.01% 2488
2024
Q3 		$585K Sell
8,282
-3,690
-31% -$257K ﹤0.01% 4799
2024
Q2 		$794K Buy
11,972
+594
+5% +$38.9K ﹤0.01% 4415
2024
Q1 		$772K Sell
11,378
-754
-6% -$49.8K ﹤0.01% 4525
2023
Q4 		$750K Buy
12,132
+5,508
+83% +$324K ﹤0.01% 4527
2023
Q3 		$391K Sell
6,624
-528
-7% -$32.4K ﹤0.01% 4632
2023
Q2 		$427K Buy
7,152
+417
+6% +$24.8K ﹤0.01% 4588
2023
Q1 		$393K Sell
6,735
-1,761
-21% -$106K ﹤0.01% 4642
2022
Q4 		$527K Sell
8,496
-42
-0.5% -$2.53K ﹤0.01% 4474
2022
Q3 		$483K Sell
8,538
-333
-4% -$20.5K ﹤0.01% 4492
2022
Q2 		$567K Sell
8,871
-828
-9% -$52.6K ﹤0.01% 4476
2022
Q1 		$628K Buy
9,699
+3,153
+48% +$200K ﹤0.01% 4556
2021
Q4 		$436K Buy
6,546
+612
+10% +$38.8K ﹤0.01% 4924
2021
Q3 		$362K Buy
5,934
+30
+0.5% +$1.91K ﹤0.01% 4909
2021
Q2 		$366K Sell
5,904
-15
-0.3% -$912 ﹤0.01% 4892
2021
Q1 		$351K Sell
5,919
-1,029
-15% -$62.1K ﹤0.01% 4882
2020
Q4 		$415K Buy
6,948
+894
+15% +$51K ﹤0.01% 4478
2020
Q3 		$326K Sell
6,054
-3,843
-39% -$207K ﹤0.01% 4164
2020
Q2 		$508K Sell
9,897
-420
-4% -$21.1K ﹤0.01% 3844
2020
Q1 		$463K Sell
10,317
-585
-5% -$29.5K ﹤0.01% 3851
2019
Q4 		$582K Sell
10,902
-3,687
-25% -$182K ﹤0.01% 4161
2019
Q3 		$680K Buy
14,589
+2,250
+18% +$108K ﹤0.01% 4038
2019
Q2 		$620K Sell
12,339
-42
-0.3% -$2.08K ﹤0.01% 4132
2019
Q1 		$635K Sell
12,381
-7,950
-39% -$396K ﹤0.01% 4069
2018
Q4 		$954K Sell
20,331
-2,412
-11% -$124K ﹤0.01% 3772
2018
Q3 		$1.27M Buy
22,743
+513
+2% +$28K ﹤0.01% 3760
2018
Q2 		$1.12M Sell
22,230
-855
-4% -$42.4K ﹤0.01% 3759
2018
Q1 		$1.14M Buy
23,085
+1,950
+9% +$100K ﹤0.01% 3605
2017
Q4 		$1.09M Sell
21,135
-876
-4% -$45K ﹤0.01% 3684
2017
Q3 		$1.14M Sell
22,011
-390
-2% -$20K ﹤0.01% 3447
2017
Q2 		$1.16M Sell
22,401
-4,671
-17% -$236K ﹤0.01% 3355
2017
Q1 		$1.36M Buy
27,072
+3,702
+16% +$183K ﹤0.01% 3261
2016
Q4 		$1.1M Buy
23,370
+3,006
+15% +$143K ﹤0.01% 3396
2016
Q3 		$1.01M Sell
20,364
-5,247
-20% -$266K ﹤0.01% 3127
2016
Q2 		$1.23M Sell
25,611
-9,189
-26% -$437K ﹤0.01% 3076
2016
Q1 		$1.59M Buy
34,800
+12,588
+57% +$589K ﹤0.01% 2817
2015
Q4 		$1.2M Sell
22,212
-4,143
-16% -$218K ﹤0.01% 3044
2015
Q3 		$1.3M Buy
26,355
+3,150
+14% +$181K ﹤0.01% 2974
2015
Q2 		$1.35M Sell
23,205
-849
-4% -$49.6K ﹤0.01% 3121
2015
Q1 		$1.38M Buy
24,054
+8,010
+50% +$438K ﹤0.01% 3048
2014
Q4 		$810K Buy
16,044
+6,954
+77% +$339K ﹤0.01% 3459
2014
Q3 		$425K Buy
9,090
+135
+2% +$6.09K ﹤0.01% 3731
2014
Q2 		$403K Sell
8,955
-5,262
-37% -$226K ﹤0.01% 3189
2014
Q1 		$600K Buy
+14,217
New +$596K ﹤0.01% 3073

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase's IHE Position: Q2 2026 in Review

JP Morgan Chase increased its iShares US Pharmaceuticals ETF (IHE) stake by 47% in Q2 2026, buying an estimated $16M and bringing the position to 553,812 shares worth $55.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

JP Morgan Chase first reported a position in IHE in Q1 2014 and has held it in 50 quarters since. 201 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • JP Morgan Chase held 553,812 shares of iShares US Pharmaceuticals ETF worth $55.5M as of Q2 2026.
  • JP Morgan Chase bought 178,066 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $16M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1398 holding.
  • JP Morgan Chase first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and has held it in 50 quarters since.
  • 201 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.